Eleanor Laise

Merck on Thursday reported fourth-quarter earnings and sales that beat analyst expectations, powered by strong growth in cancer and vaccine products.

Amgen on Tuesday reported fourth quarter profits and sales that topped analyst expectations even as revenues dropped for one of its top-selling drugs.

Lawmakers have emphasized gaps between U.S. list prices and overseas costs for a handful of drugs made by the three drugmakers.

Drugmakers grilled on the cost of prescription drugs on Capitol Hill Thursday sought to deflect the criticism onto drug-market middlemen who they said are...

Biogen on Tuesday reported fourth-quarter results that fell short of Wall Street expectations as uptake of its newer drugs failed to offset declining...

RAPT Therapeutics shares dropped more than 60% premarket on Tuesday after the company said regulators have hit pause on two clinical trials of its...

UnitedHealth Group Inc. shares UNH, fell more than 2% Tuesday after The Wall Street Journal reported that the Department of Justice has launched an antitrust investigation into the health insurance giant.

Follow all the latest U.S. market action for Tuesday here.

Pfizer Inc.’s stock rose 0.7% early Thursday, after the drug company said it has taken a step forward in developing a once-daily pill for obesity. The pharmaceutical giant said it has chosen a preferred modified-release formulation of its experimental drug danuglipron, which like Novo Nordisk’s Oze

Follow along to the action in markets on Thursday as investors await the CPI report.